Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.8204
+0.0088 (1.08%)
Oct 8, 2025, 1:59 PM EDT - Market open

Pasithea Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
6481939-
Market Cap Growth
32.33%-48.26%-58.92%-51.55%--
Enterprise Value
-1-5-11-2318-
Last Close Price
0.813.157.4012.8335.40-
PS Ratio
----2572.20-
PB Ratio
0.400.270.330.440.75-
P/TBV Ratio
0.860.640.540.570.75-
EV/Sales Ratio
----1206.82-
Debt / Equity Ratio
--0.000.01--
Asset Turnover
----0.00-
Quick Ratio
4.166.186.2217.62118.4236.90
Current Ratio
4.976.586.3418.15119.1737.55
Return on Equity (ROE)
-85.84%-72.84%-47.07%-24.97%-8.41%-
Return on Assets (ROA)
-49.52%-42.23%-28.02%-15.98%-10.52%-
Return on Capital (ROIC)
-54.76%-46.55%-30.04%-16.67%-10.91%-
Earnings Yield
-225.76%-348.55%-207.04%-74.25%-5.61%-
FCF Yield
-209.50%-349.02%-174.58%-73.52%-8.25%-
Buyback Yield / Dilution
-132.08%10.64%2.83%-142.65%-41.29%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q